July 14, 2016
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Imprimis reports 180% increase in revenue in first quarter
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Imprimis Pharmaceuticals reported $4.4 million in total revenue in the first quarter, a 180% increase compared with $1.6 million in total revenue in the same quarter of 2015, according to a press release.
Sales related to ophthalmology increased to $1.8 million compared with $320,000 in the same quarter a year ago.
Net loss was reported at $4.5 million, or $0.43 per common share, in the first quarter compared with a net loss of $3.1 million, or $0.33 per common share, in the same quarter of 2015.
General and administrative expenses were reported at $3.9 million in the first quarter compared with $2.5 million in the same quarter of 2015.